サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：タンパク質工学の世界市場- 2023-2030
市場調査レポート
商品コード
1289777

タンパク質工学の世界市場- 2023-2030

Global Protein Engineering Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
タンパク質工学の世界市場- 2023-2030
出版日: 2023年06月12日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場概要

タンパク質工学の世界市場は、2022年に22億4,720万米ドルに達し、2030年には67億2,130万米ドルに達するなど、有利な成長が予測されます。世界のタンパク質工学市場は、予測期間中（2023年～2030年）に15.2%のCAGRを示すと予測されています。

タンパク質工学は、既存の特性を改善したり、機能を追加したりするために、タンパク質を変更または開発するプロセスです。また、安定性、特異性、活性、その他の望ましい特性を高めるために、タンパク質の構造、配列、特性に手を加えることも含まれます。

世界のタンパク質工学市場は、技術開発、タンパク質ベースの医薬品に対する需要の増加、多くの分野でのタンパク質の用途の拡大により、急速に発展しています。

市場力学

タンパク質ベースの医薬品に対する需要の高まりが、世界のタンパク質工学市場を牽引すると予想される

世界のタンパク質工学市場の主な促進要因の1つは、糖尿病の頻度が高まるにつれて、タンパク質ベースの治療薬に対するニーズが高まっていることです。CDCの2022年全米糖尿病統計報告書によると、米国では3,730万人が糖尿病を患っており、総人口の11.3％を占めています。

米国では糖尿病の有病率が上昇しているため、インスリンだけでなく、タンパク質工学に基づく人工インスリンの需要も増加すると予測されています。したがって、上記の要因によって、世界のタンパク質工学市場は予測期間中に拡大すると思われます。

タンパク質工学の世界市場は、器具の高コスト別制約を受ける可能性がある

タンパク質工学には、質量分析計、クロマトグラフィーシステム、ハイスループット・スクリーニング・プラットフォームなどの高度なツールや機器の利用が必要です。このような機器は、購入、維持、改良にコストがかかることがあります。

特に、経営資源が限られている中小企業や研究機関にとっては、機器のコストが高いことが、タンパク質工学技術への投資の障壁になっています。このような理由から、世界のタンパク質工学市場は予測期間中、大きな抑制要因に直面することになるでしょう。

COVID-19の影響分析

COVID-19の流行は、治療薬や診断薬に対する需要の増加により、研究開発活動を促進し、タンパク質工学ビジネスに大きな影響を与えました。タンパク質工学のアプローチは、ワクチン開発、抗ウイルス薬の設計、診断テストの開発などに利用されています。

共同研究、資金調達、ウイルスタンパク質と免疫学的反応への研究のシフトが、タンパク質工学の進歩を後押ししています。しかし、サプライチェーンの中断により、困難が生じた。全体として、パンデミックは、世界な健康問題への取り組みにおけるタンパク質工学の関連性を強調し、この分野での技術革新に拍車をかけました。

ロシア・ウクライナ紛争分析

ロシアとウクライナの紛争は、世界のタンパク質工学産業への直接的な影響は限定的でした。しかし、サプライチェーンの混乱、経済的不安定、研究協力の緊張、人材の移動、規制の変更/貿易障壁などの間接的な反響はあり得る。

これらの要因は、資源の利用可能性、投資決定、研究資金、科学開発、タンパク質工学の世界の人材プールに影響を与える可能性があります。しかし、地政学的な対立は業界に影響を与えるいくつかの変数の一つに過ぎず、科学の発展と市場の需要がより大きな影響を与えることを強調することが重要です。

目次

第1章 調査手法と範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

  • 市場内訳：製品タイプ別
  • 市場内訳：タンパク質の種類別
  • 市場内訳：技術別
  • 市場内訳：エンドユーザー別
  • 市場内訳：地域別

第4章 市場力学

  • 影響要因
    • 促進要因
      • タンパク質ベースの医薬品に対する需要の高まり
    • 抑制要因
      • 機器のコスト高
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • 価格分析
  • 法規制の分析

第6章 COVID-19の分析

第7章 製品タイプ別

  • 消耗品
  • 楽器
  • ソフトウェア＆サービス

第8章 タンパク質の種類別

  • インスリン
  • エリスロポエチン
  • ワクチン
  • インターフェロン
  • 凝固因子
  • コロニー刺激因子
  • 成長ホルモン
  • モノクローナル抗体

第9章 技術別

  • 非合理的なタンパク質設計
  • 合理的なタンパク質設計

第10章 エンドユーザー別

  • バイオ製薬会社
  • 受託研究機関
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A（合併・買収）分析

第13章 企業プロファイル

  • GE Healthcare
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展状況
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Genscript Biotech Corporation
  • Codexis, Inc.
  • Waters Corporation
  • New England Biolabs, Inc.
  • Merck KGaA

第14章 付録

目次
Product Code: BT2684

Market Overview

The Global Protein Engineering Market reached US$ 2,247.2 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 6,721.3 million by 2030. The global protein engineering market is expected to exhibit a CAGR of 15.2% during the forecast period (2023-2030).

Protein engineering is the process of altering or developing proteins in order to improve existing characteristics or add additional functionality. It also entails tinkering with protein structure, sequence, and characteristics in order to increase their stability, specificity, activity, and other desirable traits.

The global protein engineering market is developing rapidly as a result of technological developments, rising demand for protein-based pharmaceuticals, and the expanding uses of proteins in numerous sectors.

Market Dynamics

The Growing Demand for Protein Based Drug is Expected to Drive the Global Protein Engineering Market

One of the major drivers of the worldwide protein engineering market is the increasing need for protein-based therapeutics as the frequency of diabetes rises. According to the CDC's National Diabetes Statistics Report for 2022, 37.3 million people in the United States have diabetes, accounting for 11.3% of the total population.

Because of the rising prevalence of diabetes in the United States, demand for insulin, as well as protein-engineered artificial insulin, is predicted to rise. Therefore, owing to the above factor the global protein engineering market will boost over the forecast period.

The Global Protein Engineering Market May Face Constraints due to the High Cost of Instruments

Protein engineering requires the utilization of advanced tools and equipment such as mass spectrometers, chromatography systems, and high-throughput screening platforms. Such equipment can be costly to buy, maintain, and improve.

The high cost of instruments is a barrier to investment in protein engineering technologies, particularly for small and medium-sized firms (SMEs) or research institutes with restricted resources. Owing to this reason the global protein engineering market will face a major restraint over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a substantial influence on the protein engineering business, with increasing demand for treatments and diagnostics driving research and development activities. Protein engineering approaches have been used in vaccine development, antiviral medication design, and diagnostic test development.

Collaboration, financing, and a shift in research focus to viral proteins and immunological responses have propelled advances in protein engineering. However, supply chain interruptions have presented difficulties. Overall, the pandemic has highlighted the relevance of protein engineering in tackling global health issues and has fueled innovation in the area.

Russia-Ukraine Conflict Analysis

The war between Russia and Ukraine has had a limited direct influence on the global protein engineering industry. However, indirect repercussions such as supply chain disruptions, economic instability, strained research collaborations, talent migration, and regulatory changes/trade barriers are possible.

These factors may have an impact on resource availability, investment decisions, research funding, scientific development, and the global talent pool in protein engineering. However, it is vital to highlight that geopolitical conflicts are only one of several variables influencing the industry, with scientific developments and market demand having a larger impact.

Segment Analysis

The global protein engineering market is segmented based on product type, protein type, technology, end user, and region.

The Biopharmaceutical Companies Segment is Expected to Dominate the Global Protein Engineering Market

The biopharmaceutical companies segment is projected to dominate the protein engineering market and will account for the highest market share of 52.5%, due to the high proportion utilization of in silico drug research models for treating diabetes, cancer, and neurological illnesses. For example, top pharmaceutical firms such as Novo Nordisk, AstraZeneca, and Eli Lilly have prioritized revenue growth through the discovery of novel treatments.

Furthermore, the biopharmaceutical companies segment is expanding due to increased financing and investment assistance from both public and private healthcare organizations. For instance, in March 2023, Sanofi's acquisition of Provention Bio brought a new, first-in-class medication for type 1 diabetes to its general medicines core asset portfolio. Therefore, the adoption of in-silico techniques and an increase in funding will drive the segment growth of the global protein engineering market size over the forecast period.

Geographical Analysis

North America Region Holds the Largest Market Share of the Global Protein Engineering Market

The global protein engineering market is dominated by North America and holds 2/5th market share due to better healthcare spending, technological advancements, presence of major market players leading to drug development, collaboration, and advanced healthcare infrastructure.

For instance, in January 2023. Proteinea, a biotech startup based in the U.S. and Egypt, is pioneering computational protein engineering technology, as they are releasing Ankh, the most sophisticated and high-performing open-source protein language model in the world. Proteinea created Ankh in collaboration with Google and the Technical University of Munich, using funding from Google's cloud innovators program.

Competitive Landscape

The major global players in the market include: GE Healthcare, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Bruker Corporation, Genscript Biotech Corporation, Codexis, Waters Corporation, New England Biolabs, and Merck KGaA.

Why Purchase the Report?

  • To visualize global protein engineering market segmentation based on product type, protein type, technology, end user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global protein engineering market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global protein engineering market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Protein Type
  • 3.3. Market Snippet by Technology
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The growing demand for protein-based drug
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of instruments
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Consumables
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Instruments
  • 7.4. Software & Services

8. By Protein Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 8.1.2. Market Attractiveness Index, By Protein Type
  • 8.2. Insulin
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Erythropoietin
  • 8.4. Vaccines
  • 8.5. Interferons
  • 8.6. Coagulation Factors
  • 8.7. Colony-Stimulating Factors
  • 8.8. Growth Hormones
  • 8.9. Monoclonal Antibodies

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Irrational Protein Design
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Rational Protein Design

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Biopharmaceutical Companies*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Contract Research Organizations
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. GE Healthcare*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Thermo Fisher Scientific, Inc.
  • 13.3. Agilent Technologies, Inc.
  • 13.4. Bio-Rad Laboratories, Inc.
  • 13.5. Bruker Corporation
  • 13.6. Genscript Biotech Corporation
  • 13.7. Codexis, Inc.
  • 13.8. Waters Corporation
  • 13.9. New England Biolabs, Inc.
  • 13.10. Merck KGaA

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us